OBJECTIVE: To develop rapid (< 8 hour) tests using polymerase chain reaction (PCR) for the diagnosis of equine herpesvirus 3 (EHV3; equine coital exanthema virus), equine gammaherpesviruses 2 (EHV2) and EHV5, equine adenovirus 1 (EAdV1), EAdV2, equine arteritis virus (EAV), equine rhinitis A virus (ERAV; formerly equine rhinovirus 1) DESIGN: Either single round or second round (seminested) PCRs were developed and validated. METHODS: Oligonucleotide primers were designed that were specific for each virus, PCR conditions were defined and the specificity and sensitivity of the assays were determined. The application of the tests was validated using a number of independent virus isolates for most of the viruses studied. The PCRs were applied directly to clinical samples where samples were available. RESULTS: We developed a single round PCR for the diagnosis of EHV3, a seminested PCR for EHV2 and single round PCRs for EHV5, EAdV1, EAdV2 and RT-PCRs for EAV and ERAV. The PCR primer sets for each virus were designed and shown to be highly specific (did not amplify any recognised non-target template) and sensitive (detection of minimal amounts of virus) and, where multiple virus isolates were available all isolates were detected. CONCLUSION: The development and validation of a comprehensive panel of PCR diagnostic tests, predominantly for viruses causing equine respiratory disease, that can be completed within 8 hours from receipt of clinical samples, provides a major advance in the rapid diagnosis or exclusion diagnosis of these endemic equine virus diseases in Australia.
OBJECTIVE: To develop rapid (< 8 hour) tests using polymerase chain reaction (PCR) for the diagnosis of equine herpesvirus 3 (EHV3; equine coital exanthema virus), equine gammaherpesviruses 2 (EHV2) and EHV5, equine adenovirus 1 (EAdV1), EAdV2, equine arteritis virus (EAV), equine rhinitis A virus (ERAV; formerly equine rhinovirus 1) DESIGN: Either single round or second round (seminested) PCRs were developed and validated. METHODS: Oligonucleotide primers were designed that were specific for each virus, PCR conditions were defined and the specificity and sensitivity of the assays were determined. The application of the tests was validated using a number of independent virus isolates for most of the viruses studied. The PCRs were applied directly to clinical samples where samples were available. RESULTS: We developed a single round PCR for the diagnosis of EHV3, a seminested PCR for EHV2 and single round PCRs for EHV5, EAdV1, EAdV2 and RT-PCRs for EAV and ERAV. The PCR primer sets for each virus were designed and shown to be highly specific (did not amplify any recognised non-target template) and sensitive (detection of minimal amounts of virus) and, where multiple virus isolates were available all isolates were detected. CONCLUSION: The development and validation of a comprehensive panel of PCR diagnostic tests, predominantly for viruses causing equinerespiratory disease, that can be completed within 8 hours from receipt of clinical samples, provides a major advance in the rapid diagnosis or exclusion diagnosis of these endemic equine virus diseases in Australia.
Authors: Mathias Franz; Alex D Greenwood; Peter A Seeber; Anisha Dayaram; Florian Sicks; Nikolaus Osterrieder Journal: Appl Environ Microbiol Date: 2019-01-23 Impact factor: 4.792
Authors: Katharine E Muscat; Barbara Padalino; Carol A Hartley; Nino Ficorilli; Pietro Celi; Peter Knight; Sharanne Raidal; James R Gilkerson; Gary Muscatello Journal: Front Vet Sci Date: 2018-09-25
Authors: Walid Azab; Sameh Bedair; Azza Abdelgawad; Kathrin Eschke; Gemelat K Farag; Ali Abdel-Raheim; Alex D Greenwood; Nikolaus Osterrieder; Ahmed A H Ali Journal: Vet Med Sci Date: 2019-05-31
Authors: Kurt J Williams; N Edward Robinson; Ailam Lim; Christina Brandenberger; Roger Maes; Ashley Behan; Steven R Bolin Journal: PLoS One Date: 2013-10-11 Impact factor: 3.240
Authors: Sigríður Björnsdóttir; Simon R Harris; Vilhjálmur Svansson; Eggert Gunnarsson; Ólöf G Sigurðardóttir; Kristina Gammeljord; Karen F Steward; J Richard Newton; Carl Robinson; Amelia R L Charbonneau; Julian Parkhill; Matthew T G Holden; Andrew S Waller Journal: mBio Date: 2017-08-01 Impact factor: 7.867